C

Cigna Group
XMUN:CGN

Watchlist Manager
Cigna Group
XMUN:CGN
Watchlist
Price: 232.2 EUR -1.74%
Market Cap: 67.9B EUR

Intrinsic Value

The intrinsic value of one CGN stock under the Base Case scenario is 523.73 EUR. Compared to the current market price of 232.2 EUR, Cigna Group is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGN Intrinsic Value
523.73 EUR
Undervaluation 56%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cigna Group

What is Valuation History?
Ask AI Assistant
What other research platforms think about CGN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CGN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cigna Group.

Explain Valuation
Compare CGN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
Bear Theses

Intensifying federal and state scrutiny of the pharmacy benefit management industry, especially around drug pricing transparency and rebate structures, could significantly compress Cigna’s Evernorth margins, undermining one of its core growth drivers.

Growing competition from insurtech disruptors and rival managed-care providers places pressure on Cigna’s commercial membership, potentially leading to slower enrollment growth or higher costs to retain existing clients.

Complexities from large-scale integrations, such as the Express Scripts acquisition, may sap resources and weigh on profitability if anticipated synergies fail to materialize or if operational and cultural alignments lag expectations.

Bull Theses

Evernorth’s diversified services, ranging from pharmacy benefit management to specialty pharmacy solutions, position Cigna to capture a larger share of healthcare spending and enhance cross-selling opportunities in both commercial and government segments.

Cigna’s proven ability to manage medical cost trends, combined with strategic investments in analytics and value-based care programs, supports stable margins and differentiates the company in a competitive market.

The company’s international footprint, particularly in high-growth markets for supplemental health and expatriate benefits, provides additional avenues for revenue expansion and mitigates domestic market volatility.

Show More Less
How do you feel about CGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cigna Group

Current Assets 46.7B
Cash & Short-Term Investments 6.9B
Receivables 31.7B
Other Current Assets 8.1B
Non-Current Assets 111.2B
Long-Term Investments 18.5B
PP&E 3.7B
Intangibles 73.9B
Other Non-Current Assets 15.2B
Current Liabilities 56.5B
Accounts Payable 9.3B
Accrued Liabilities 7.7B
Other Current Liabilities 39.4B
Non-Current Liabilities 59.7B
Long-Term Debt 30.9B
Other Non-Current Liabilities 28.7B
Efficiency

Free Cash Flow Analysis
Cigna Group

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cigna Group

Revenue
268.1B USD
Cost of Revenue
-242.5B USD
Gross Profit
25.6B USD
Operating Expenses
-15.6B USD
Operating Income
10B USD
Other Expenses
-3.8B USD
Net Income
6.1B USD
Fundamental Scores

CGN Profitability Score
Profitability Due Diligence

Cigna Group's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive ROE
Positive 3Y Average ROE
Gross Margin is Increasing
ROIC is Increasing
48/100
Profitability
Score

Cigna Group's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

CGN Solvency Score
Solvency Due Diligence

Cigna Group's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
44/100
Solvency
Score

Cigna Group's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGN Price Targets Summary
Cigna Group

There are no price targets for CGN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CGN stock?

The intrinsic value of one CGN stock under the Base Case scenario is 523.73 EUR.

Is CGN stock undervalued or overvalued?

Compared to the current market price of 232.2 EUR, Cigna Group is Undervalued by 56%.

Back to Top